Conceptual Re-Engineering: From Explication ... - Georg Brun
Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute
-
Upload
giovanni-lynagh -
Category
Documents
-
view
46 -
download
5
description
Transcript of Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute
![Page 1: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/1.jpg)
Modeling of the three antifungal agent combination (Amphotericin B + Micafungin + Nikkomycin Z) against Aspergillus fumigatus
in vitro using
a novel response surface paradigm
Yseult F. BrunCancer Prevention and Population Sciences,
Roswell Park Cancer InstituteUB School of Pharmacy and Pharmaceutical
Sciences / Novartis fellowship
![Page 2: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/2.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Acknowledgements
Brahm H. Segal Carly Dennis William R. Greco Donald B. White
![Page 3: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/3.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Experimental Methods
Aspergillus fumigatus, 3.9 103 per well
Amphotericin B, Nikkomycin Z and Micafungin.
Randomized 96 well plates XTT assay after 24 hour exposure.
![Page 4: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/4.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Our Unique Dataset
91 different fixed ratios at 11 log spaced increasing amounts
At least, quadruplicates 5 separate experiments Controls and drugs alone for each
experiment 5610 data points
![Page 5: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/5.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Hill Equation – Single Drug
slope m
Emax/2 + b
b
CONCENTRATION(Log scale)
0.001 0.01 0.1 1 10 100 1000
EFFECT(% control)
0
50
100
Econ
IC50
Emax =Econ - b
bICC
ICCbEconE
m
m
)/(1
)/(*)(
50
50
![Page 6: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/6.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Model challenges
Model must take into account the following challenges: Different slope parameters for each
agent
Arbitrary patterns for slope, background parameters
Irregular isobols, local synergy, antagonism, additivity
More than 2 agents
![Page 7: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/7.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Example of hill model fitted to data from one
fixed-ratio
[FK ]+ [Nikk]+[ampho] (g/mL)
1e-5 1e-4 1e-3 0.01 0.1 1 10 100 1000
Res
po
nse
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8FK:nikk:ampho 8:2:1
![Page 8: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/8.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Scaled concentrations
2,50
2
1,50
1
50
50
)/(1
)/)((
ICC
ICCA
BCIA
CIABEconE
m
m
![Page 9: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/9.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Example of isobol and Log CI50
Nikkomycin Z + FK463
[FK]/IC50,FK
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6
[Nik
k]/I
C50
,nik
k
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
% IC50 equivalents of FK
0.0 0.2 0.4 0.6 0.8 1.0
CI5
0 (l
og
sca
le)
0.1
1
10
)]()[1)(1()50( 21 yxyxyxyxyxCILOG
![Page 10: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/10.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Ternary Plot
![Page 11: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/11.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Three-drug Hierarchical Model Example
Effect(V,A, ) =
100)),(/(1
)),(/100
),(50
),(50
EconB%(V,θ
CIA
CIAEconB%(V,θ
EconB
mD
mD
B
m
m
V
V
V
V
![Page 12: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/12.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Conclusions
Effective modeling system Complex response surface, projection of
irregular isobols The most synergistic region is at the
center of the response surface, for approximately equal normalized amounts of the three agents, amphotericin B, nikkomycin Z and micafungin
Thank you!
![Page 13: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/13.jpg)
Extra slides
![Page 14: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/14.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Randomization
![Page 15: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/15.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Weighting
![Page 16: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/16.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Example for B
2210 ** xBxBBB
![Page 17: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/17.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Using Scheffé’s Polynomials
Example With Slope B Third Order model for B in three drug
experiment: B(V,B) =
xyzzyyzzxxzyxxy
yzxzxyzyx
BBBB
BBBBBB
123231312
231312321
)()()(
![Page 18: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/18.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Example for slope parameter for two drugs
2210 ** xmxmmm
![Page 19: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/19.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Example for m – three drugs
m observed
-5 -4 -3 -2 -1 0
m p
red
icte
d
-5
-4
-3
-2
-1
0
Expt AExpt BExpt CExpt DExpt Ered one drug, purple two, blue three
![Page 20: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/20.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Modifications for CI50 ModelsTo Account for Scaling
Model Log(CI50) in place of CI50
Note the leading factor (1-x)(1-y)(1-z) - forces the polynomial to zero
at the single drug vertices
LogCI50(V,D) =
])()()(
)[1)(1)(1(
123231312
231312321
xyzzyyzzxxzyxxy
yzxzxyzyxzyx
DDDD
DDDDDD
![Page 21: Yseult F. Brun Cancer Prevention and Population Sciences, Roswell Park Cancer Institute](https://reader035.fdocuments.us/reader035/viewer/2022062304/56812d15550346895d91fcd0/html5/thumbnails/21.jpg)
December 19th 2005 ISAP presentation – antifungals modeling
Log CI50 fit for three drugs
Log CI50 observed
-0.8 -0.6 -0.4 -0.2 0.0 0.2 0.4 0.6 0.8 1.0
Log
CI5
0 es
timat
ed
-0.8
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0